Skip to main content
Year archive

ACTINOGEN MEDICAL LIMITED — 2021 filings

All 63 regulatory filings released by ACTINOGEN MEDICAL LIMITED (ACW) in 2021, sourced directly from the official regulator.

63 Filings
2021 Period
2021 filings (63)
Filing Released Lang
Appendix 3Y - Dr Geoff Brooke 2 pages 203.2KB
Director's Dealing
2021-12-20 English
Appendix 3Y - Dr George Morstyn 2 pages 203.1KB
Director's Dealing
2021-12-20 English
Appendix 3Y - Mr Malcolm McComas 2 pages 202.9KB
Director's Dealing
2021-12-20 English
Capital Raising Completion 3 pages 243.7KB
Capital/Financing Update
2021-12-19 English
Application for quotation of securities - ACW 6 pages 27.7KB
Share Issue/Capital Change
2021-12-19 English
New clinical advisory boards 4 pages 260.8KB
Board/Management Information
2021-12-08 English
ACW Strategic Collaboration with Oxford Uni Researchers 2 pages 187.2KB
Regulatory Filings
2021-12-06 English
Cleansing Notice 1 page 243.8KB
Capital/Financing Update
2021-11-30 English
Application for quotation of securities - ACW 5 pages 26.2KB
Capital/Financing Update
2021-11-29 English
XanaMIA Part A trial achieves target enrolment 2 pages 210.9KB
Regulatory Filings
2021-11-28 English
Cleansing Notice - Share Purchase Plan 1 page 244.8
Capital/Financing Update
2021-11-28 English
Share Purchase Plan Offer Booklet 16 pages 315.1KB
Capital/Financing Update
2021-11-28 English
Offer to Participate in Share Purchase Plan 3 pages 239.6KB
Capital/Financing Update
2021-11-28 English
Program Expansion & Capital Raising 5 pages 278.3KB
Capital/Financing Update
2021-11-24 English
Strategic Update & Capital Raising Investor Presentation 34 pages 6.8MB
Investor Presentation
2021-11-24 English
Proposed issue of securities - ACW 11 pages 40.6KB
Capital/Financing Update
2021-11-24 English
Cleansing Notice - Share Purchase Plan 1 page 221.0
Capital/Financing Update
2021-11-24 English
Trading Halt 2 pages 280.0KB
Capital/Financing Update
2021-11-22 English
Application for quotation of securities - ACW 7 pages 29.9KB
Share Issue/Capital Change
2021-11-17 English
Appendix 3Y - Dr Geoff Brooke 2 pages 202.9KB
Director's Dealing
2021-11-17 English
Appendix 3Y - Dr George Morstyn 2 pages 203.0KB
Director's Dealing
2021-11-17 English
Appendix 3Y - Mr Malcolm McComas 2 pages 203.0KB
Director's Dealing
2021-11-17 English
AGM Presentations 27 pages 6.7MB
AGM Information
2021-11-09 English
Results of Annual General Meeting 4 pages 226.4KB
Declaration of Voting Results & Voting Rights Announcements
2021-11-09 English
ACW announces open IND for Phase 2 Fragile X trial & LOI 2 pages 243.2KB
Regulatory Filings
2021-11-08 English
Quarterly Activity Report & Appendix 4C 8 pages 420.1KB
Interim / Quarterly Report
2021-10-19 English
R&D Tax Incentive Rebate received of A$1.435 million 2 pages 206.0KB
Regulatory Filings
2021-10-12 English
Letter to Shareholders & Notice of Annual General Meeting 44 pages 800.2KB
AGM Information
2021-10-07 English
Annual Report to Shareholders 88 pages 5.2MB
Regulatory Filings
2021-10-07 English
Date of AGM and Closing Date for Director Nominations 2 pages 165.1KB
AGM Information
2021-09-21 English
Application for quotation of securities - ACW 7 pages 31.8KB
Share Issue/Capital Change
2021-09-15 English
Appendix 4E & Annual Report 82 pages 2.9MB
Annual Report
2021-08-29 English
Actinogen Medical FY21 Results- Progressing the Pipeline 4 pages 242.0KB
Annual Report
2021-08-29 English
Appendix 4G 13 pages 159.8KB
Regulatory Filings
2021-08-29 English
Actinogen completes global patent family grant 2 pages 203.1KB
Regulatory Filings
2021-08-22 English
Actinogen to present at ShareCafe Small Cap Webinar 16 pages 2.6MB
Investor Presentation
2021-08-03 English
Quarterly Activity Report & Appendix 4C 8 pages 246.4KB
Interim / Quarterly Report
2021-07-21 English
First Patient Enrolled in XanaMIA trial 2 pages 195.2KB
Regulatory Filings
2021-07-14 English
Actinogen receives positive Pre-IND FDA advice for FXS 2 pages 182.8KB
Capital/Financing Update
2021-06-22 English
Clinical progress for XanaMIA trial 2 pages 143.6KB
Regulatory Filings
2021-06-20 English
Actinogen Ethics Committee approval for XanaMIA study 2 pages 168.9KB
Regulatory Filings
2021-06-01 English
Change of Share Register Notification 2 pages 189.6KB
Regulatory Filings
2021-05-27 English
Response to ASX Price Query 4 pages 299.4KB
Regulatory Filings
2021-05-23 English
Lapse of Unlisted Options 2 pages 165.4KB
Capital/Financing Update
2021-05-09 English
Strategic Update Teleconference Transcript 7 pages 214.2KB
Call Transcript
2021-04-29 English
Quarterly Activity Report & Appendix 4C 8 pages 245.1KB
Interim / Quarterly Report
2021-04-20 English
Strategic Update & Teleconference Call Notification 28 pages 3.0MB
Investor Presentation
2021-04-20 English
Appendix 3Y - Dr George Morstyn 2 pages 27.8KB
Director's Dealing
2021-03-28 English
Actinogen CEO assumes Managing Director position 2 pages 168.6KB
Board/Management Information
2021-03-23 English
Initial Director's Interest Notice 2 pages 183.5KB
Director's Dealing
2021-03-23 English
Actinogen appoints Dr Steven Gourlay as CEO 5 pages 223.1KB
Board/Management Information
2021-03-14 English
Appendix 2A 17 pages 186.5KB
Capital/Financing Update
2021-03-14 English
Appendix 4D & Half-Year Financial Statements 25 pages 469.4KB
Interim / Quarterly Report
2021-02-23 English
Change in substantial holding 3 pages 96.0KB
Major Shareholding Notification
2021-02-11 English
ACW raises an addtional $3.55m under a Shortfall Placement 2 pages 168.8KB
Capital/Financing Update
2021-02-09 English
Appendix 2A 15 pages 173.4KB
Regulatory Filings
2021-02-09 English
Cleansing Notice 1 page 390.0KB
Capital/Financing Update
2021-02-09 English
Expiry of Unlisted Options 2 pages 171.8KB
Capital/Financing Update
2021-02-07 English
Resignation of Dr Bill Ketelbey as Chief Executive Officer 2 pages 167.9KB
Board/Management Information
2021-02-07 English
Final Director's Interest Notice 2 pages 29.5KB
Director's Dealing
2021-02-07 English
Pause in Trading 1 page 110.9KB
Regulatory Filings
2021-02-04 English
FDA Grants ACW Rare Paediatric Disease Designation in FXS 3 pages 222.4KB
Capital/Financing Update
2021-02-04 English
Quarterly Activity Report & Appendix 4C 9 pages 252.0KB
Interim / Quarterly Report
2021-01-28 English